EXOZ eXoZymes, Inc. logo

EXOZ eXoZymes, Inc.

Healthcare
$9.92+5.53%ClosedMarket Cap: $84.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

54.91

P/S

0.00

EV/EBITDA

-8.50

DCF Value

$0.14

FCF Yield

-8.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-220.6%

ROA

-240.7%

ROIC

-362.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-2.4M$
Q4 null$0.00$-2.7M$
FY null$0.00$-9.2M$
Q3 null$0.00$-2.3M$

Trading Activity

Insider Trades

View All
Korman Tyler Pazofficer: Chief Scientific Officer
SellFri Apr 10
Perriman Damien Alanofficer: Chief Commercial Officer
SellWed Apr 08
Perriman Damien Alanofficer: Chief Commercial Officer
SellWed Apr 08
Perriman Damien Alanofficer: Chief Commercial Officer
SellWed Apr 08
Perriman Damien Alanofficer
SellWed Apr 08

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

2.86

eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

Peers